WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2020> 31> 5

Volume: 31 Issue: 5

1. Pushing the envelope: expanding fertility sparing treatment of endometrial cance Page:e82—
2. Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study Page:e74—
3. Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept Page:e86—
4. Erratum: Author Correction.Management of ovarian cancer patients in affected areas during COVID-19 pandemic: Japan and Korea Page:e87—
5. Comprehensive pelvic and paraaortic lymphadenectomy in patients with apparently early stage uterine serous carcinoma – an anachronism? Page:e76—
6. Potential strategies for prevention of tumor spillage in minimally invasive radical hysterectomy Page:e73—
7. Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells Page:e75—
8. Vulvar melanoma: an analysis of prognostic factors and treatment patterns Page:e66—
9. Feasibility of laparoscopic diaphragmatic peritonectomy during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer Page:e71—
10. Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis Page:e67—
11. Should indications for laterally extended endopelvic resection (LEER) exclude patients with sciatica? Page:e63—
12. Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma Page:e64—
13. Incidence and clinical course of septic shock in neutropenic patients during chemotherapy for gynecological cancers Page:e62—
14. Incidence and predictors of peritoneal metastases of gynecological origin:a population-based study in the Netherlands Page:e58—
15. Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women Page:e60—
16. Pushing the envelope: expanding fertility sparing treatment of endometrial cance Page:e82—
17. Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study Page:e74—
18. Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept Page:e86—
19. Erratum: Author Correction.Management of ovarian cancer patients in affected areas during COVID-19 pandemic: Japan and Korea Page:e87—
20. Comprehensive pelvic and paraaortic lymphadenectomy in patients with apparently early stage uterine serous carcinoma – an anachronism? Page:e76—
21. Potential strategies for prevention of tumor spillage in minimally invasive radical hysterectomy Page:e73—
22. Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells Page:e75—
23. Vulvar melanoma: an analysis of prognostic factors and treatment patterns Page:e66—
24. Feasibility of laparoscopic diaphragmatic peritonectomy during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer Page:e71—
25. Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis Page:e67—
26. Should indications for laterally extended endopelvic resection (LEER) exclude patients with sciatica? Page:e63—
27. Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma Page:e64—
28. Incidence and clinical course of septic shock in neutropenic patients during chemotherapy for gynecological cancers Page:e62—
29. Incidence and predictors of peritoneal metastases of gynecological origin:a population-based study in the Netherlands Page:e58—
30. Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women Page:e60—

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.